These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32905523)

  • 41. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway.
    Zou J; Yang Y; Yang Y; Liu X
    Biomed Pharmacother; 2018 Dec; 108():130-136. PubMed ID: 30218857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
    Dai W; Liu H; Xu X; Ge J; Luo S; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
    Int J Cancer; 2019 Nov; 145(10):2619-2628. PubMed ID: 30734280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
    Xie K; Wang C; Qin N; Yang J; Zhu M; Dai J; Jin G; Shen H; Ma H; Hu Z
    Oncotarget; 2016 Jul; 7(30):47966-47974. PubMed ID: 27374108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis.
    Imani D; Azimi A; Salehi Z; Rezaei N; Emamnejad R; Sadr M; Izad M
    Int J Immunogenet; 2018 Dec; 45(6):329-336. PubMed ID: 30264444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic Variants in One-Carbon Metabolism Pathway Predict Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer.
    Do SK; Choi SH; Lee SY; Choi JE; Kang HG; Hong MJ; Kim JH; Baek SA; Lee JH; Lee WK; Do YW; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
    Oncology; 2020; 98(12):897-904. PubMed ID: 32791502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression Quantitative Trait Locus Study of Bone Mineral Density GWAS Variants in Human Osteoclasts.
    Mullin BH; Zhu K; Xu J; Brown SJ; Mullin S; Tickner J; Pavlos NJ; Dudbridge F; Walsh JP; Wilson SG
    J Bone Miner Res; 2018 Jun; 33(6):1044-1051. PubMed ID: 29473973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
    Zhao XK; Mao YM; Meng H; Song X; Hu SJ; Lv S; Cheng R; Zhang TJ; Han XN; Ren JL; Qi YJ; Wang LD
    PLoS One; 2017; 12(5):e0177504. PubMed ID: 28542283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
    Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
    Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival.
    Wang X; Liu H; Xu Y; Xie J; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Song Y; Wei Q
    Carcinogenesis; 2019 Apr; 40(2):279-288. PubMed ID: 30596980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
    Li D; Wei L; Xu B; Yu D; Chang J; Yuan P; Du Z; Tan W; Shen H; Wu T; Wu C; Lin D
    PLoS One; 2014; 9(11):e113574. PubMed ID: 25415319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.
    Qian J; Liu H; Gu S; Wu Q; Zhao X; Wu W; Wang H; Wang J; Chen H; Zhang W; Wei Q; Jin L; Lu D
    Clin Lung Cancer; 2015 Sep; 16(5):e37-53. PubMed ID: 25818095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes.
    Zheng Y; Zhang D; Zhang L; Fu M; Zeng Y; Russell R
    Gene; 2013 Nov; 530(1):151-4. PubMed ID: 23973727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression Quantitative Trait Loci Information Improves Predictive Modeling of Disease Relevance of Non-Coding Genetic Variation.
    Croteau-Chonka DC; Rogers AJ; Raj T; McGeachie MJ; Qiu W; Ziniti JP; Stubbs BJ; Liang L; Martinez FD; Strunk RC; Lemanske RF; Liu AH; Stranger BE; Carey VJ; Raby BA
    PLoS One; 2015; 10(10):e0140758. PubMed ID: 26474488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.
    Ungerbäck J; Belenki D; Jawad ul-Hassan A; Fredrikson M; Fransén K; Elander N; Verma D; Söderkvist P
    Carcinogenesis; 2012 Nov; 33(11):2126-34. PubMed ID: 22843550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
    Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
    Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
    Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
    Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.